AP News

Correction: Ranbaxy Laboratories-CEO story


PLAINSBORO TOWNSHIP, N.J. (AP) — In a July 9 story about Indian drugmaker Ranbaxy Laboratories Ltd., The Associated Press erroneously reported that the company will launch a generic version of acne drug Accutane in about six months. The product is slightly different than Accutane and will be sold under the brand name Absorica.


Toyota's Hydrogen Man
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus